Gert Jan Fleuren

15.6k citations

234 papers · 12.6k indexed · 1 hit paper · h-index 61

Immunology top 0.2%
Oncology top 0.2%
Molecular Biology top 2%
Epidemiology top 0.5%
Surgery top 2%

Co-authors: Gemma G. Kenter Sjoerd H. van der Burg Ekaterina S. Jordanova Cornelis J.M. Melief Rienk Offringa Arko Gorter Cees J. Cornelisse Jan W. Drijfhout
Topics: Cervical Cancer and HPV Research (64 papers)Immunotherapy and Immune Responses (56 papers)Immune Cell Function and Interaction (36 papers)
Cited by: Immunology Oncology Reproductive Medicine
Journals: New England Journal of Medicine Proceedings of the National Academy of Sciences The Journal of Experimental Medicine
Partner nations: Netherlands United States Indonesia

In The Last Decade

Gert Jan Fleuren

232 papers receiving 12.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia

2009 803 citations Gemma G. Kenter, Marij J.P. Welters et al. profile →

Peers

Countries citing papers authored by Gert Jan Fleuren

Since Specialization

Citations

This map shows the geographic impact of Gert Jan Fleuren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gert Jan Fleuren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gert Jan Fleuren more than expected).

Fields of papers citing papers by Gert Jan Fleuren

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gert Jan Fleuren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gert Jan Fleuren. The network helps show where Gert Jan Fleuren may publish in the future.

Co-authorship network of co-authors of Gert Jan Fleuren

This figure shows the co-authorship network connecting the top 25 collaborators of Gert Jan Fleuren. A scholar is included among the top collaborators of Gert Jan Fleuren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gert Jan Fleuren. Gert Jan Fleuren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Possible different genotypes for human papillomavirus vaccination in lower middle-income countries towards cervical cancer elimination in 2030: a cross-sectional study 2022 ·Clinical and Experimental Vaccine Research ·(unknown),(unknown),(unknown),(unknown),Gert Jan Fleuren,Ekaterina S. Jordanova,(unknown),Ahmad Rusdan Handoyo Utomo	3
2	Correlations between immune response and vascularization qRT-PCR gene expression clusters in squamous cervical cancer 2015 ·Molecular Cancer ·Simone Punt,Jeanine J. Houwing‐Duistermaat,Iris A. Schulkens,Victor L. Thijssen,Elisabeth M. Osse,Cor D. de Kroon,Arjan W. Griffioen,Gert Jan Fleuren,Arko Gorter,Ekaterina S. Jordanova	39
3	Searching for metastases in ovarian tissue before autotransplantation: a tailor-made approach 2014 ·Fertility and Sterility ·(unknown),Vincent T.H.B.M. Smit,Timothy P. Fleming,L Louwe,Gert Jan Fleuren,Carina G. J. M. Hilders	23
4	Target-Enriched Next-Generation Sequencing Reveals Differences between Primary and Secondary Ovarian Tumors in Formalin-Fixed, Paraffin-Embedded Tissue 2014 ·Journal of Molecular Diagnostics ·(unknown),Dina Ruano,Ronald van Eijk,Gert Jan Fleuren,(unknown),(unknown),Carli M.J. Tops,Tom van Wezel,Hans Morreau	8
5	Ovarian tissue cryopreservation: analyzing ovarian tissue with different techniques to rule out micrometastases in patients with different kinds of primary tumors 2012 ·Fertility and Sterility ·(unknown),Vincent T.H.B.M. Smit,L Louwe,Gert Jan Fleuren,Carina G. J. M. Hilders	0
6	CXCR7 expression is associated with disease-free and disease-specific survival in cervical cancer patients 2012 ·British Journal of Cancer ·Marlies Schrevel,Rezaul Karim,Natalja T. ter Haar,Sjoerd H. van der Burg,J. Baptist Trimbos,Gert Jan Fleuren,Arko Gorter,Ekaterina S. Jordanova	55
7	Versican expression is associated with tumor-infiltrating CD8-positive T cells and infiltration depth in cervical cancer 2010 ·Modern Pathology ·Arko Gorter,Henry Zijlmans,(unknown),J. Baptist Trimbos,Gert Jan Fleuren,Ekaterina S. Jordanova	44
8	Genome-wide Allelic State Analysis on Flow-Sorted Tumor Fractions Provides an Accurate Measure of Chromosomal Aberrations 2008 ·Cancer Research ·Willem E. Corver,Anneke Middeldorp,Natalja T. ter Haar,Ekaterina S. Jordanova,Marjo van Puijenbroek,Ronald van Eijk,Cees J. Cornelisse,Gert Jan Fleuren,Hans Morreau,Jan Oosting,Tom van Wezel	30
9	Robust T-cell responses and clinical responses following long peptide vaccination against high risk HPV-16 2008 ·Cornelis J.M. Melief,Marij J.P. Welters,Margriet J. Löwik,Annelies P.G. Vloon,Jan W. Drijfhout,A. Rob P.M. Valentijn,Amon R. Wafelman,Gert Jan Fleuren,Rienk Offringa,Sjoerd H. van der Burg,Gemma G. Kenter	1
10	Expression and genetic analysis of transporter associated with antigen processing in cervical carcinoma 2007 ·Gynecologic Oncology ·Christine Vermeulen,Ekaterina S. Jordanova,Natalja T. ter Haar,Sandra Kolkman-Uljee,Noel F.C.C. de Miranda,Soldano Ferrone,(unknown),Gert Jan Fleuren	17
11	Distinct regulation and impact of type 1 T‐cell immunity against HPV16 L1, E2 and E6 antigens during HPV16‐induced cervical infection and neoplasia 2005 ·International Journal of Cancer ·Mariëtte I.E. van Poelgeest,Esther R. Nijhuis,Kitty M.C. Kwappenberg,(unknown),Jan W. Drijfhout,Gert Jan Fleuren,Ate G.J. van der Zee,Cornelis J.M. Melief,Gemma G. Kenter,Hans W. Nijman,Rienk Offringa,Sjoerd H. van der Burg	34
12	Enhancement of the complement activating capacity of 17-1A mAb to overcome the effect of membrane-bound complement regulatory proteins on colorectal carcinoma 2002 ·European Journal of Immunology ·Kyra A. Gelderman,Peter J.K. Kuppen,(unknown),Gert Jan Fleuren,Arko Gorter	1
13	Enhancement of the complement activating capacity of 17-1A mAb to overcome the effect of membrane-bound complement regulatory proteins on colorectal carcinoma 2002 ·European Journal of Immunology ·Kyra A. Gelderman,Peter J.K. Kuppen,(unknown),Gert Jan Fleuren,Arko Gorter	40
14	HLA and susceptibility to cervical neoplasia 1999 ·Human Immunology ·E. J. T. Krul,R.F. Schipper,G. M. T. Schreuder,Gert Jan Fleuren,Gemma G. Kenter,Cornelis J.M. Melief	67
15	Evidence of clonal divergence in colorectal carcinoma 1997 ·Cancer ·Rob A.�E.�M. Tollenaar,Bert A. Bonsing,Nel J. Kuipers‐Dijkshoorn,J. Hermans,Cornelis J.�H. van de Velde,Cees J. Cornelisse,Gert Jan Fleuren	2
16	Evidence of clonal divergence in colorectal carcinoma 1997 ·Cancer ·Rob A.�E.�M. Tollenaar,Bert A. Bonsing,Nel J. Kuipers‐Dijkshoorn,J. Hermans,Cornelis J.�H. van de Velde,Cees J. Cornelisse,Gert Jan Fleuren	22
17	p53 protein overexpression is common and independent of human papillomavirus infection in squamous cell carcinoma of the vulva 1997 ·Cancer ·Marjolein J. Kagie,Gemma G. Kenter,Rob A.�E.�M. Tollenaar,Jo Hermans,J. Baptist Trimbos,Gert Jan Fleuren	36
18	Serum CA 125 Levels in Patients with a Provisional Diagnosis of Pelvic Inflammatory Disease: Clinical and Theoretical Implications 1989 ·Acta Obstetricia Et Gynecologica Scandinavica ·Jitze M. Duk,(unknown),Gert Jan Fleuren,H.W.A. de Bruijn	20
19	Differentiated thyroid cancer: a stage adapted approach to the treatment of regional lymph node metastases 1988 ·European Journal of Cancer and Clinical Oncology ·Jaap F. Hamming,Cornelis J.�H. van de Velde,Gert Jan Fleuren,B. M. Goslings	30
20	Demonstration of transplantation antigens on the endothelium of peritubular capillaries in renal allografts by the immunoperoxidase method. 1979 ·PubMed ·(unknown),van Es La,Gert Jan Fleuren	4

About Gert Jan Fleuren

Gert Jan Fleuren is a scholar working on Immunology, Reproductive Medicine and Oncology, having authored 234 papers that have together received 12.6k indexed citations. Recurring topics across this work include Cervical Cancer and HPV Research (64 papers), Immunotherapy and Immune Responses (56 papers) and Immune Cell Function and Interaction (36 papers). The work is most often cited by research in Immunology (5.8k citations), Oncology (4.8k citations) and Reproductive Medicine (1.2k citations). Gert Jan Fleuren has collaborated with scholars based in Netherlands, United States and Indonesia. Frequent co-authors include Gemma G. Kenter, Sjoerd H. van der Burg, Ekaterina S. Jordanova, Cornelis J.M. Melief, Rienk Offringa, Arko Gorter, Cees J. Cornelisse, Jan W. Drijfhout, Marij J.P. Welters and S. O. Warnaar. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Journal of Experimental Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact